Cite
The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing
MLA
Regina F Gandour-Edwards, et al. “The JAX Patient-Derived Xenograft Program: A Unique Resource to Advance Genome-Guided Cancer Medicine and Therapeutic Agent Testing.” Journal of Clinical Oncology, vol. 32, May 2014, p. e22151. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6614191f6a725bf33d9c0f70fc8e8a17&authtype=sso&custid=ns315887.
APA
Regina F Gandour-Edwards, Clifford G. Tepper, Xing Yi Woo, Lenny Shultz, Tianhong Li, Joshy George, Carol J. Bult, Joel H. Graber, Yan Yang, Philip C. Mack, Hyun-Soo Kim, Jeffrey H. Chuang, Primo N. Lara, R. Krishna Murthy Karuturi, Edison T. Liu, James L. Keck, Rebekah A. Burich, David R. Gandara, Ralph de Vere White, & Susan D. Airhart. (2014). The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing. Journal of Clinical Oncology, 32, e22151.
Chicago
Regina F Gandour-Edwards, Clifford G. Tepper, Xing Yi Woo, Lenny Shultz, Tianhong Li, Joshy George, Carol J. Bult, et al. 2014. “The JAX Patient-Derived Xenograft Program: A Unique Resource to Advance Genome-Guided Cancer Medicine and Therapeutic Agent Testing.” Journal of Clinical Oncology 32 (May): e22151. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6614191f6a725bf33d9c0f70fc8e8a17&authtype=sso&custid=ns315887.